DXCM vs SWBI · P/E 63, rev $2.50B vs P/E 62, rev $523.8M
DexCom Inc (DXCM) versus Smith & Wesson Brands Inc (SWBI) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Smith & Wesson Brands Inc (SWBI) is a aerospace & defense company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported SWBI revenue for 2026-04-30 was $523.8M. Net income was $18.5M. Revenue was up 10.4% from 2025-04-30 to 2026-04-30. SWBI currently screens at market cap $659.4M and trailing P/E 61.8.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. SWBI currently screens at market cap $659.4M and trailing P/E 61.8.
Not investment advice. Open the DXCM and SWBI stock pages for the full models.
Not investment advice.